首款3D立体成钉腔镜吻合器亮相进博会，将降低术中出血风险

Core Insights - Johnson & Johnson Medical Technology launched the ETHICON™ 4000 laparoscopic stapler at the China International Import Expo, marking its first introduction in Asia and aimed at serving Chinese patients [2] - The ETHICON™ 4000 features the world's first 3D stapling technology, representing a significant advancement from traditional 2D stapling methods, thus entering a new era of laparoscopic anastomosis technology [6] Technological Breakthrough - The ETHICON™ 4000 overcomes limitations of traditional B-type flat stapling technology, which struggles with uneven tissue thickness and fragile tissue, leading to issues like leakage and increased risk of complications [4] - The device's 3D stapling structure enhances tissue conformity, improving the integrity and stability of sutures, while the innovative preset chip technology allows real-time monitoring and adjustment during the stapling process [6] Clinical Value - The introduction of the 3D stapling system is associated with a 23% reduction in the incidence of interventions due to bleeding during surgery, which correlates with decreased risks of bleeding and tissue leakage [7] - This advancement is expected to reduce postoperative complications, shorten hospital stays, and alleviate the physical and financial burdens on patients [7] - The launch of the ETHICON™ 4000 is seen as a milestone in the evolution of laparoscopic stapling technology in China, reflecting the company's commitment to innovation driven by clinical needs [7]